Quest Diagnostics integrates cancer tests into Flatiron's OncoEMR platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TXN
3. NOW
4. TSLA
5. GOOG
6. CSX
7. IBM
8. KNX
9. LVS
10. INTC

Go back to Quest Diagnostics integrates cancer tests into Flatiron's OncoEMR platform
Quest Diagnostics (NYSE: DGX) Delayed: 225.11 +15.28 (7.28%)
Previous Close $209.83    52 Week High $86.85 
Open $228.09    52 Week Low $59.66 
Day High $237.78    P/E 42.39 
Day Low $223.65    EPS $5.31 
Volume 1,812,597